// App-Quantinova.ai

: Serum Protein Markers of Survival, Relapse and GvHD Identified within the First Two Weeks Post Stem Cell Transplantation

Researchers

Presenter

  • Kriti Verma

Principal Investigators

  • Wayne Croft

  • David Greenwood

  • Christine Stephens

  • Francesca A Kinsella

  • Paul Moss

Medical Centers

  • Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom

  • Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Graft-versus-host disease

Biomarkers

  • Nucleoside diphosphate kinase A

  • CUB domain containing protein 1

  • Programmed death-ligand 1

  • Interleukin 10

  • Interleukin 6

  • Interleukin-2

Drug/Treatment

  • Interleukin-10

Outcome

  • N/A

Study Design

  • Safety

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved